Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Rahul Jain Profile picture
Rahul Jain
@jain_7199rahul
Company Secretary by Profession / Living the journey of Stock Markets #investing
Feb 7 • 9 tweets • 2 min read
KRN Heat Exchanger and Refrigeration Limited Q3 FY '25 earnings conference call summary

Business Areas: Manufacturing heat exchangers, with broad applications in HVAC, refrigeration, railways, automotive, and industrial cooling.

#krn #krnheat #Concall Q3 FY25 Financial Performance:

Revenue: 116.36 crores (73.67% YoY growth)
EBITDA: 15.81 crores (34.76% YoY growth)
Net Profit: 13.73 crores (74.44% YoY growth)

9-Month Figures: Revenue at INR 305.88 crores (+32.96% YoY); Net Profit INR 38.01 crores (+39.02% YoY).

#krnheat
May 10, 2022 • 20 tweets • 9 min read
A thread on Cosmo Films Limited

Source: Investor PPT

#cosmofilms #investing Image ⚡️Cosmo Films the pioneer of BOPP (Biaxially Oriented PolyPropylene) Films Industry in India.

⚡️It is also the world’s largest producer of thermal lamination films.
Jan 12, 2022 • 38 tweets • 11 min read
A thread on Antony Waste Handling Cell Limited
(Managing Waste. Delivering Growth)
#AWHCL #antonywaste Before beginning, let understand the Importance of waste management in today’s world

1. The growing population is causing negative impact on our society. The current model of production & consumption generates a lot of waste that, in many cases, does not get reused or recycled.
Jan 6, 2022 • 28 tweets • 8 min read
A thread on #glandpharma

Incorporated in 1978, Gland Pharma is an injectables-focused B2B player with capabilities for both API & formulations that derives 2/3rd of its revenue from the US, Row (16%) & India (9%). Injectables account for 98% of its revenue while Ophthalmic fetches 2%. It is one of the fastest growing generic injectables-focused companies.